Literature DB >> 25202076

Microarray analysis of gene expression in lung cancer cell lines treated by fractionated irradiation.

Sung-Ja Ahn1, Chan Choi2, Yoo-Duk Choi3, Young-Chul Kim4, Kyu-Sik Kim4, In-Jae Oh4, Hee-Jung Ban4, Mee-Sun Yoon1, Taek-Keun Nam1, Jae-Uk Jeong1, Joo-Young Song1, Woong-Ki Chung1.   

Abstract

BACKGROUND: To identify differentially expressed genes between parent and radioresistant lung cancer cell lines established by fractionated irradiation.
MATERIALS AND METHODS: Lung cancer cell lines (A549, NCI-H1650) were irradiated with several fractionation schemes. Clonogenic assays were used to identify radioresistant cell lines. We compared the gene expression profiles on a cDNA microarray.
RESULTS: Four established cell (A549-2G, A549-5G, H1650-2G and H1650-5G) were shown to be radioresistant (p≤0.05). Seventy-two genes were commonly altered in A549-G and 655 genes in H1650-G, compared to their parental cells. Genes in the wingless-type MMTV integration site family (WNT) signaling pathway were the ones most frequently altered in both A549-G and H1650-G cells. Those involved in inflammation; integrin, platelet-derived growth factor (PDGF), interleukin, transforming growth factor-beta (TGFB), epidermal growth factor receptor (EGFR) signaling, were commonly altered in radioresistant H1650 sublines.
CONCLUSION: The major gene expression changes during irradiation are related to WNT signaling pathway. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Non-small cell lung cancer; cDNA miroarrays; fractionated irradiation; radioresistance

Mesh:

Year:  2014        PMID: 25202076

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  5 in total

1.  Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling.

Authors:  Georg Emons; Melanie Spitzner; Sebastian Reineke; Janneke Möller; Noam Auslander; Frank Kramer; Yue Hu; Tim Beissbarth; Hendrik A Wolff; Margret Rave-Fränk; Elisabeth Heßmann; Jochen Gaedcke; B Michael Ghadimi; Steven A Johnsen; Thomas Ried; Marian Grade
Journal:  Mol Cancer Res       Date:  2017-08-15       Impact factor: 5.852

2.  Identification of novel NRAGE involved in the radioresistance of esophageal cancer cells.

Authors:  Huandi Zhou; Ge Zhang; Xiaoying Xue; Yanling Yang; Ye Yang; Xiaojing Chang; Xiaohui Ge; Zhiqing Xiao; Han Guo; Yanqiang Wang
Journal:  Tumour Biol       Date:  2016-01-07

3.  Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation.

Authors:  Ruben S A Goedegebuure; Esther A Kleibeuker; Francesca M Buffa; Kitty C M Castricum; Syed Haider; Iris A Schulkens; Luuk Ten Kroode; Jaap van den Berg; Maarten A J M Jacobs; Anne-Marie van Berkel; Nicole C T van Grieken; Sarah Derks; Ben J Slotman; Henk M W Verheul; Adrian L Harris; Victor L Thijssen
Journal:  J Exp Clin Cancer Res       Date:  2021-05-08

4.  Overexpression of Wnt7a enhances radiosensitivity of non-small-cell lung cancer via the Wnt/JNK pathway.

Authors:  Pingping Ai; Xianhua Xu; Shijie Xu; Zhixia Wei; Shun Tan; Junzhe Li
Journal:  Biol Open       Date:  2020-06-27       Impact factor: 2.422

5.  Genome-wide DNA methylation analyses in lung adenocarcinomas: Association with EGFR, KRAS and TP53 mutation status, gene expression and prognosis.

Authors:  Maria Moksnes Bjaanæs; Thomas Fleischer; Ann Rita Halvorsen; Antoine Daunay; Florence Busato; Steinar Solberg; Lars Jørgensen; Elin Kure; Hege Edvardsen; Anne-Lise Børresen-Dale; Odd Terje Brustugun; Jörg Tost; Vessela Kristensen; Åslaug Helland
Journal:  Mol Oncol       Date:  2015-11-06       Impact factor: 6.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.